| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
| filingDate |
2015-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfacf3ffacba9c213068714d081f39d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07559a98f8c131132bdc46cdc39f3b52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba8a47757dc0c8ceac3af42aff42407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dcde36228e62e7556498f865c8a0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f1000e4fe9507c5739d7111bafcd1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9490fdd746e729f17affebda1f8b9f2 |
| publicationDate |
2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015258207-A1 |
| titleOfInvention |
Prodrugs comprising an insulin linker conjugate |
| abstract |
The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising an insulin linker conjugate D-L, wherein D represents the insulin moiety; and -L is a non-biologically active linker moiety -L 1 represented by formula (I), n n n n n n n n n n wherein the dashed line indicates the attachment to one of the amino groups of the insulin by forming an amide bond. The invention further relates to pharmaceutical compositions comprising said prodrugs as well as their use as a medicament for treating or preventing diseases or disorders which can be treated by insulin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018100174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018213151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11141489-B2 |
| priorityDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |